Qiagen price target raised to $52 from $49 at TD Cowen

TD Cowen analyst Dan Brennan raised the firm’s price target on Qiagen (QGEN) to $52 from $49 and keeps a Hold rating on the shares. Following a modest beat and raise print, the conference call was largely “steady as she goes,” with CEO/CFO discussing ongoing traction with the growth of their 5 Pillars enhanced via numerous R&D initiatives, navigating through tariff margin pressures, and a consistent capital allocation strategy, the firm notes.